scPharmaceuticals Inc. financial data

Symbol
SCPH on Nasdaq
Industry
Pharmaceutical Preparations
Location
25 Burlington Mall Road, Suite 203, Burlington, MA
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 682 % -35.3%
Quick Ratio 82.8 %
Debt-to-equity 187 % +164%
Return On Equity -202 % -174%
Return On Assets -70.4 % -62.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 50M shares +39.5%
Common Stock, Shares, Outstanding 36.1M shares +0.81%
Entity Public Float 274M USD +263%
Common Stock, Value, Issued 4K USD 0%
Weighted Average Number of Shares Outstanding, Basic 39M shares +0.76%
Weighted Average Number of Shares Outstanding, Diluted 39M shares +0.76%

Income Statement

Label TTM Value / Value Unit Change %
Cost of Revenue 6.94M USD +550%
Research and Development Expense 12.2M USD +9.63%
General and Administrative Expense 20.6M USD +111%
Operating Income (Loss) -60.4M USD -34.8%
Net Income (Loss) Attributable to Parent -60.6M USD -35.4%
Earnings Per Share, Basic -1.56 USD/shares -17.3%
Earnings Per Share, Diluted -1.56 USD/shares -17.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 38.5M USD -46%
Accounts Receivable, after Allowance for Credit Loss, Current 6.12M USD +280%
Inventory, Net 15.3M USD +162%
Other Assets, Current 340K USD +2991%
Assets, Current 62.6M USD -44.9%
Property, Plant and Equipment, Net 47K USD +4.44%
Operating Lease, Right-of-Use Asset 1.31M USD +261%
Assets 65.5M USD -42.7%
Accounts Payable, Current 5.29M USD +348%
Employee-related Liabilities, Current 3.2M USD +34.9%
Accrued Liabilities, Current 7.4M USD +44.5%
Liabilities, Current 12.9M USD +94.9%
Operating Lease, Liability, Noncurrent 1.18M USD +29500%
Other Liabilities, Noncurrent 263K USD +171%
Liabilities 56.2M USD +10.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1K USD -103%
Retained Earnings (Accumulated Deficit) -313M USD -24.1%
Stockholders' Equity Attributable to Parent 9.25M USD -85.4%
Liabilities and Equity 65.5M USD -42.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -17.7M USD -7.32%
Net Cash Provided by (Used in) Financing Activities 13.7M USD
Net Cash Provided by (Used in) Investing Activities 29.3M USD +319%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 36.1M shares +0.81%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 11.6M USD +176%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 38.5M USD -46%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.47M USD -1.08%
Deferred Tax Assets, Valuation Allowance 73.2M USD +23.8%
Deferred Tax Assets, Gross 74.3M USD +24.9%
Operating Lease, Liability 1.37M USD +407%
Depreciation 23K USD -25.8%
Payments to Acquire Property, Plant, and Equipment 6K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -60.6M USD -35.4%
Lessee, Operating Lease, Liability, to be Paid 1.84M USD +553%
Property, Plant and Equipment, Gross 119K USD -51.4%
Operating Lease, Liability, Current 190K USD -28.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 349K USD +34800%
Lessee, Operating Lease, Liability, to be Paid, Year One 341K USD +3689%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure +19.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 461K USD +4510%
Lessee, Operating Lease, Liability, to be Paid, Year Three 358K USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 1.24M USD +11.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four 367K USD
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 5.63M USD +52.9%
Interest Expense 8.39M USD +33%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%